BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia
Recruiting · NCT06746519 · Registry updated 2024-12-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| BN104 in Combination With Chemotherapy or Targeted Agents for Acute Myeloid Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Recruiting | Phase 1 / Phase 2 | 2024-12-24 | NCT06746519 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| BioNova Pharmaceuticals (Shanghai) LTD. | 1 |
| Chen Suning | 3 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| The First Affiliated Hospital of Soochow University | Suzhou | China | 36 |